Hyman, Phelps & McNamara, P.C. Director Douglas B. Farquhar is a key presenter at the Food and Drug Law Institute’s (“FDLI’s”) upcoming conference in São Paulo, Brazil. The conference, which is scheduled for September 10-11, 2012, is titled “U.S. & Brazil: Navigating New Frontiers in Pharmaceutical, Medical Device & Food Law & Regulation,” and will focus on business opportunities and policy challenges of producing safe products and promoting public health. Mr. Farquhar, who will discuss FDA enforcement activities relating to imported medical devices, will be joined by government officials and other internationally renowned experts who will discuss pharmaceutical, medical device and food law, regulation, and policy in the United States and Brazil. A copy of the conference agenda is available here.
Brazil, one of the so-called “BRICS” countries, is rapidly emerging as a world leader in innovation and development in the pharmaceutical, medical device, and food industries. Stakeholders ranging from multinational companies to small startups are staking a foothold in the region. FDA and the Brazilian National Health Surveillance Agency (“ANVISA”) are working together to safeguard the integrity of the products being exchanged between the two countries, and, by extension, across the globe. Understanding the current legal, regulatory, and economic environment for the development and sale of pharmaceuticals, medical devices, and foods in in the United States and Brazil is imperative for anyone doing business, or working with clients who are doing business, between the two countries.
FDA Law Blog readers can receive a 15% discount off the conference registration price. To receive the discount, use the following promotional code: BRAZIL2012. To register for the event click here.